SpringerProtocols: Abstract: Lentivirus Vector-Mediated Gene Transfer to Cardiomyocytes

Lentivirus Vector-Mediated Gene Transfer to Cardiomyocytes

By: Tsuyoshi Sakoda³, Noriyuki Kasahara^{3 4}, Larry Kedes^{3 5}

Abstract

Full Text

Download PDF (246K)

Gene therapy has the potential to reverse the genetic causes and modify the pathophysiology of many innate and acquired diseases (1–4). Transduction of foreign DNA into cardiac myocytes is of potential value for therapeutic applications (5,6) and also offers an experimental approach to investigate the roles of individual genes in cardiovascular pathophysiology. Both efficient delivery and long-term expression of transduced genes is required before the full benefit of genetic manipulation strategies can be realized in the cardiovascular system. However, all the current methods of gene delivery have major limitations.

Affiliation(s): (3) Institute for Genetic Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA
(4) Department of Pathology, Keck School of Medicine, University of Southern California, Los Angeles, CA
(5) Department of Biochemistry and Molecular Biology, Keck School of Medicine, University of Southern California, Los Angeles, CA

Book Title: Cardiac Cell and Gene Transfer: Principles, Protocols, and Applications

Series: Methods in Molecular Biology | Volume: 219 | Pub. Date: Dec-19-2002 | Page Range: 53-70 | DOI: 10.1385/1-59259-350-X:53

Subject: Genetics/Genomics

References

Download References

1.	Mulligan, R. C. (1993) The basic science of gene therapy. Science 260, 926–932.

2.	Crystal, R. G. (1995) Transfer of genes to humans: early lessons and obstacles to success. Science 270, 404–410.

3.	Leiden, J. M. (1995) Gene therapy-promise, pitfalls, and prognosis. N. Engl. J. Med. 333, 871–873.

4.	Verma, I. M. and Somia, N. (1997) Gene therapy—promises, problems and prospects. Nature 389, 239–242.

5.	Lafont, A., Guerot, C., and Lemarchand, P. (1996) Prospects for gene therapy in cardiovascular disease. Eur. Heart J. 17, 1312–1317.

6.	Partridge, T. A. and Davies, K. E. (1995) Myoblast-based gene therapies. Br. Med. Bull. 51, 123–137.

7.	Shi, Y., Ford, A., Vernami, P., and Zalewski, A. (1994) Transgene expression in the coronary circulation: transcatheter gene delivery. Gene Ther. 1, 408–414.

8.	Schulick, A. H., Newman, K. D., Virmani, R., and Dichek, D. A. (1995) In vivo gene transfer into injured carotid arteries. Optimization and evaluation of acute toxicity. Circulation 91, 2407–2414.

9.	Lewis, P. F. and Emerman, M. (1994) Passage through mitosis is required for oncoretroviruses but not for the human immunodeficiency virus. J. Virol. 68, 510–516.

10.	Naldini, L., Blomer, U., Gallay, P., et al., (1996) In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272, 263–267.

11.	Burns, J. C., Friedmann, T., Driever, W., Burrascano, M., and Yec, J. K. (1993) Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells. Proc. Natl. Acad. Sci. USA 90, 8033–8037.

12.	Naldini, L., Blomer, U., Gage, F. H., Trono, D., and Verma, I. M. (1996) Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. Proc. Natl. Acad. Sci. USA 93, 11,382–11,388.

13.	Miyake, K., Suzuki, N., Matsucka, H., Tohyama, T., and Shimada, T. (1998) Stable integration of human immunodeficiency virus-based retroviral vectors into the chromosomes of nondividing cells. Hum. Gene Ther. 9, 467–475.

14.	Blomer, U., Naldini, L., Verma, I. M., Trono, D., and Gage, F. H. (1996) Applications of gene therapy to the CNS. Hum. Mol. Genet. 5, 1397–1404.

15.	Kafri, T., Blomer, U., Peterson, D. A., Gage, F. H., and Verma, I. M. (1997) Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors. Nat. Genet. 17, 314–317.

16.	Sakoda, T., Kasahara, N., Hammano, Y., and Kedes, L. (1999) A high-titer lentiviral production system mediates efficient transduction of differentiated cells including beating cardiac myocytes. J. Mol. Cell Cardiol. 31, 2037–2047.

17.	Page, K. A., Landau, N. R., and Littman, D. R. (1990) Construction and use of a human immunodeficiency virus vector for analysis of virus infectivity. J. Virol. 64, 5270–5276.

18.	Shimada, T., Fujii, H., Mitsuya, H., and Nienhuis, A. W. (1991) Targeted and highly efficient gene transfer into CD4⁺ cells by a recombinant human immunodeficiency virus retroviral vector. J. Clin. Invest. 88, 1043–1047.

19.	Buchschacher, G. L., Jr. and Panganiban, A. T. (1992) Human immunodeficiency virus vectors for inducible expression of foreign genes. J. Virol. 66, 2731–2739.

20.	Rebolledo, M. A., Krogstad, P., Chen, F., Shannon, K. M., and Klitzner, J. S. (1998) Infection of human fetal cardiac myocytes by a human immunodeficiency virus-1-derived vector. Circ. Res. 83, 738–742.

21.	Mochizuki, H., Schwartz, J. P., Tanaka, K., Brady, R. O., and Reiser, J. (1998) High-titer human immunodeficiency virus type 1-based vector systems for gene delivery into nondividing cells. J. Virol. 72, 8873–8883.

22.	Sussman, M. A., Hamm-Alvarez, S. F., Vilalta, P. M., Welch, S., and Kedes, L. (1997) Involvement of phosphorylation in doxorubicin-mediated myofibril degeneration. An immunofluorescence microscopy analysis. Circ. Res. 80, 52–61.

23.	Ueyama, T., Sakoda, T., Kauashima, S., et al. (1997) Activated RhoA stimulates c-fos gene expression in myocardial cells. Circ. Res. 81, 672–678.

24.	Price, J., Turner, D., and Cepko, C. (1987) Lineage analysis in the vertebrate nervous system by retrovirus-mediated gene transfer. Proc. Natl. Acad. Sci. USA 84, 156–160.

25.	Chen, C. and Okayama, H. (1987)High-efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell Biol. 7, 2745–2752.

26.	Sakoda, T., Kaibuchi, K., Kishi, K., et al. (1992) smg/rap1/Krev-1 p21s inhibit the signal pathway to the c-fos promoter/enhancer from c-Ki-ras p21 but not from c-raf-1 kinase in NIH3T3 cells. Oncogene 7, 1705–1711.

27.	Sanes, J. R., Rubenstein, J. L., and Nicolas, J. F. (1986) Use of a recombinant retrovirus to study post-implantation cell lineage in mouse embryos. EMBO J. 5, 3133–3142.

28.	Radsak, K., Fuhrmann, R., Franke, R. P., et al., Induction by sodium butyrate of cytomegalovirus replication in human endothelial cells. Arch. Virol. 107, 151–158.

29.	Saemundsen, A. K., Kallin, B., and Klein, G. (1980) Effect of n-butyrate on cellular and viral DNA synthesis in cells latently infected with Epstein-Barr virus. Virology 107, 557–561.

30.	Ash, R. J. (1986) Butyrate-induced reversal of herpes simplex virus restriction in neuroblastoma cells. Virology 155, 584–592.

31.	Bohan, C., York, D., and Srinivasan, A. (1987) Sodium butyrate activates human immunodeficiency virus long terminal repeat-directed expression. Biochem. Biophys. Res. Commun. 148, 899–905.

32.	Zufferey, R., Nagy, D., Mandel, R. J., Naldini, L., and Trono, D. (1997) Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo. Nat. Biotechnol. 15, 871–875.

33.	Dull, T., Zufferey, R., Kelly, M., et al. (1998) A third-generation lentivirus vector with a conditional packaging system. J. Virol. 72, 8463–8471.

34.	Zufferey, R., Dull, T., Mardel, R. J., et al. (1998) Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery. J. Virol. 72, 9873–9880.

Comments (Loading...)

Post comment/View all comments